Work

Supplementary Figure S1 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Year: 2023
Type: supplementary-materials
Abstract: Clinical outcomes in Cohorts A (left) and B (right). A) progression-free survival; B) overall survival.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4383535587
Cites:
Cited by:
Related to: 10